Types of Cancer We Treat

Pancreatic Cancer

We combine evidence-based medicine with compassionate, personalized care to diagnose and treat people with pancreatic cancer. Our team of specialists is at the forefront of groundbreaking research, studying promising new treatments and pioneering methods for detecting pancreatic cancer earlier, when it’s most treatable.

At our Pancreatic Cancer Center, we create an individualized treatment plan for you, drawing on our expertise in endoscopic and surgical treatments as well as medical therapies.

Meet Our Doctors
Dr. Diane Simeone
Our Approach to Treating Pancreatic Cancer Our Approach to Pancreatic Cancer Treatment
Diagnosis
Diagnosing Pancreatic Cancer
Surgery
Surgery for Pancreatic Cancer
Chemotherapy & Targeted Drugs
Chemotherapy & Targeted Drugs for Pancreatic Cancer
Radiation Therapy
Radiation Therapy for Pancreatic Cancer

Related News

Pancreatic Tumor Cells Release Key Immune Signal
Read Story
Study Reveals How Pancreatic Cells Avert Starvation
Read Story
Expert Discusses Early Detection of Pancreatic Cancer
Read Story
New Program Aims to Stop Pancreatic Cancer Before It Starts
Read Story
Fungi May Drive Pancreatic Cancer
Read Story
Fungal Invasion of Pancreas Creates Cancer Risk
Read Story
Early Detection Can Improve Survival for Pancreatic Cancer
Read Story
Gene Action Needed for Early Steps Toward Pancreatic Cancer
Read Story
Pancreatic Cancer Can Be Detected Early
Read Story
New Drug to Be Tested for Treating Pancreatic Cancer
Read Story
Pancreatic Cancer Forum Hosted on Long Island
Read Story
An Ambitious Research Strategy to Fight Pancreatic Cancer
Read Story

Clinical Trials and Research Studies

Phase 3

A Phase 3 Randomized Double-Blind Study of Pamrevlumab or Placebo in combination with Gemcitabine Plus Nab-Paclitaxel as Neoadjuvant Treatment in Patients with Locally Advanced Unresectable Pancreatic Cancer

Learn More

Phase 1/2

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation

Learn More

Phase 1/2

A Phase 1/2 Study of Oral LOXO-292 in Patients With Advanced Solid Tumors Including RET Fusion-Positive Solid Tumors Medullary Thyroid Cancer and Other Tumors With RET Activation (LIBRETTO-001)

Learn More

Phase 3

A Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of FOLFIRINOX (FFX) versus Combination of CPI-613 with modified FOLFIRINOX (mFFX) in Patients with Metastatic Adenocarcinoma of the Pancreas

Learn More
View All Related Clinical Trials (8)